Premium
Antidepressant, including TCA, prescribing up in Canadian children and adolescents
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30473
Subject(s) - antidepressant , fluoxetine , psychiatry , medicine , tricyclic antidepressant , depression (economics) , serotonin reuptake inhibitor , suicidal ideation , sertraline , psychopharmacology , population , poison control , suicide prevention , serotonin , medical emergency , anxiety , receptor , macroeconomics , environmental health , economics
Antidepressant prescribing for Canadian children is increasing, with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), the most frequently prescribed medication, which was not surprising. However, there is also an increase in prescribing of tricyclic antidepressants (TCAs), which, for a pediatric population, is unexpected. And most often, the TCAs — which are toxic at high doses — are being prescribed for a condition other than depression. According to a study published in the Journal of Child and Adolescent Psychopharmacology , one of the only ones looking at antidepressant prescribing in Canada for children following the 2004 warning of suicidal ideation, which was followed by a decrease in prescribing and a subsequent increase in suicides, antidepressant prescribing is on the increase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom